The SIOPE Nursing Working Group is inviting applications for four positions on its Steering Committee, offering an exciting opportunity for nurses to help shape the future of paediatric oncology nursing across Europe. The vacancies include one position following the resignation of a Steering Committee member, one position following the completion of a committee member's term [...]

The 18th SIOP Asia Congress took place in Ulaanbaatar, Mongolia — 25–28 June 2026.

242 participants from almost 50 countries gathered in Ulaanbaatar this June for the SIOP Asia 2026 Congress, hosted at the Corporate Convention Center under the theme “Together for Change: Science, Compassion, and Hope for Every Child.”

Join global paediatric oncology experts in this CME-accredited online course to explore the physical, psychosocial, and rehabilitative management of late effects following childhood cancer treatment.

The webinar recording for “Ototoxicity: Prevention Trials and Clinical Perspectives” is now available in the Knowledge Centre under the Survivorship Network, offering expert insights and vital survivor perspectives on managing treatment-related hearing loss in paediatric oncology.

Pediatric Blood & Cancer, a leading journal dedicated to research on blood disorders and malignant diseases in children, adolescents, and young adults, has released its latest performance metrics.

IPOS has launched a new International Delphi Study on Psychosocial Oncology, and SIOP is pleased to share this important initiative with our network.

Join us on July 14th, 2026 for a webinar exploring the implementation of fertility preservation guidelines across multiple sites.

SAN ANTONIO, TEXAS – June 2026 — The Organizing Committee of the forthcoming SIOP North America (SIOP NA) – Sociedad Latinoamericana de Oncología Pediátrica (SLAOP) Conference 2026 is pleased to announce the support of the Wilms Cancer Foundation (WCF) as an official conference sponsor for this important international gathering of pediatric oncology professionals, researchers, healthcare leaders, advocacy organizations, patient representatives, and childhood cancer stakeholders.